Merit Medical Systems (MMSI) Scheduled to Post Quarterly Earnings on Wednesday

Merit Medical Systems (NASDAQ:MMSI) will post its quarterly earnings results after the market closes on Wednesday, October 30th. Analysts expect Merit Medical Systems to post earnings of $0.80 per share for the quarter. Merit Medical Systems has set its FY24 guidance at $3.27-3.35 EPS.Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $0.92 earnings per share for the quarter, beating analysts’ consensus estimates of $0.88 by $0.04. The firm had revenue of $338.00 million for the quarter, compared to analysts’ expectations of $334.94 million. Merit Medical Systems had a net margin of 9.02% and a return on equity of 15.29%. On average, analysts expect Merit Medical Systems to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Merit Medical Systems Trading Up 0.1 %

Shares of MMSI stock opened at $96.00 on Monday. The stock has a market cap of $5.59 billion, a price-to-earnings ratio of 48.00, a price-to-earnings-growth ratio of 2.41 and a beta of 0.87. The company has a quick ratio of 4.64, a current ratio of 6.24 and a debt-to-equity ratio of 0.62. Merit Medical Systems has a fifty-two week low of $63.13 and a fifty-two week high of $101.60. The firm’s 50 day moving average price is $96.11 and its two-hundred day moving average price is $87.15.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Wells Fargo & Company boosted their target price on shares of Merit Medical Systems from $85.00 to $103.00 and gave the stock an “equal weight” rating in a research report on Monday, September 16th. Canaccord Genuity Group boosted their target price on shares of Merit Medical Systems from $102.00 to $125.00 and gave the stock a “buy” rating in a research report on Tuesday, July 2nd. Needham & Company LLC reissued a “buy” rating and set a $105.00 target price on shares of Merit Medical Systems in a research report on Monday, September 16th. Piper Sandler reissued an “overweight” rating and set a $110.00 target price (up from $100.00) on shares of Merit Medical Systems in a research report on Monday, September 9th. Finally, Barrington Research reissued an “outperform” rating and set a $114.00 target price on shares of Merit Medical Systems in a research report on Friday, October 18th. Two analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Merit Medical Systems has a consensus rating of “Moderate Buy” and a consensus price target of $101.82.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.